Cereius operates as a preclinical stage company developing novel approaches to diagnosing and treating cancer
Cereius operates as a preclinical stage company developing novel approaches to diagnosing and treating cancer. It offers proprietary radiolabeling chemistries that increase the uptake and retention of radionuclides at the target tumor.